EDITORIAL
Published on 08 Dec 2022
Editorial: Immunotherapy for NSCLC with oncogenic driver variants
doi 10.3389/fonc.2022.1095947
- 664 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy for NSCLC with Oncogenic Driver Variants
Immunotherapy for NSCLC with Oncogenic Driver Variants
28k
Total Downloads
73k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 09 Mar 2022
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
doi 10.3389/fimmu.2021.749461
- 2,912 views
- 4 citations
CASE REPORT
Published on 22 Feb 2022
Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy
doi 10.3389/fonc.2022.765997
- 1,654 views
- 5 citations
ORIGINAL RESEARCH
Published on 21 Feb 2022
Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
doi 10.3389/fimmu.2022.811601
- 4,709 views
- 9 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
doi 10.3389/fimmu.2022.813072
- 4,698 views
- 42 citations
ORIGINAL RESEARCH
Published on 21 Dec 2021
ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
doi 10.3389/fimmu.2021.788985
- 5,403 views
- 12 citations
ORIGINAL RESEARCH
Published on 23 Nov 2021
Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation
doi 10.3389/fonc.2021.739090
- 2,706 views
- 26 citations
ORIGINAL RESEARCH
Published on 05 Nov 2021
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
doi 10.3389/fonc.2021.755341
- 4,931 views
- 18 citations
CASE REPORT
Published on 04 Nov 2021
Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma
doi 10.3389/fimmu.2021.686057
- 1,394 views
- 1 citation
ORIGINAL RESEARCH
Published on 01 Oct 2021
Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
doi 10.3389/fonc.2021.680402
- 3,152 views
- 11 citations
CASE REPORT
Published on 23 Sep 2021
Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
doi 10.3389/fonc.2021.731429
- 1,539 views
- 6 citations
ORIGINAL RESEARCH
Published on 20 Sep 2021
Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI
doi 10.3389/fonc.2021.700023
- 2,231 views
- 6 citations
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 73kTopic views
- 42kArticle views
- 28kArticle downloads